Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention
- DOI
- 10.20996/1819-6446-2025-3241
- Published
- 1
- Container
- Рациональная фармакотерапия в кардиологии
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.20996/1819-6446-2025-3241,
title = {Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention},
author = {O. A. Saygina and T. S. Sukhinina and M. A. Terenicheva and O. V. Stukalova and M. G. Chashchin and D. V. Pevsner},
year = {2026},
journal = {Рациональная фармакотерапия в кардиологии},
doi = {10.20996/1819-6446-2025-3241},
url = {https://doi.org/10.20996/1819-6446-2025-3241}
}RIS
TY - JOUR TI - Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention AU - O. A. Saygina AU - T. S. Sukhinina AU - M. A. Terenicheva AU - O. V. Stukalova AU - M. G. Chashchin AU - D. V. Pevsner PY - 2026 JO - Рациональная фармакотерапия в кардиологии DO - 10.20996/1819-6446-2025-3241 UR - https://doi.org/10.20996/1819-6446-2025-3241 ER -
APA
Saygina, O. A., Sukhinina, T. S., Terenicheva, M. A., Stukalova, O. V., Chashchin, M. G., & Pevsner, D. V. (2026). Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. Рациональная фармакотерапия в кардиологии. https://doi.org/10.20996/1819-6446-2025-3241
Source records
- doaj · retrieved 2026-09-26T00:45:51.302Z